Calvin Shaw, PhD Google Dr. Shaw is a Biomedical Engineer with expertise in MRI and optical imaging. In the realm of MRI, his focus areas include MRI physics, protocol development, artifact reduction algorithms, real-time MRI, compressed-sensing MRI, and constrained image reconstruction. In the realm of optical imaging, Dr. Shaw has particular expertise in solving forward […]
Chihiro Sato, PhD Linkedin Google Dr. Sato is a Research Instructor in the Department of Neurology. She is currently researching the kinetics of tau in the human central nervous system in vivo and in vitro. She is also interested in studying tau profile in Alzheimer’s disease and various tauopathies hoping to improve early diagnostics.
Pannos Roussos, PhD Linkedin Twitter Google Panos Roussos is an Associate Professor of Psychiatry and Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. He is a member of Icahn Institute – Genomics and Multiscale Biology and Friedman Brain Institute. He is also a VA/MIRECC Research Physician at the James J.
Catrina Robinson, PhD Linkedin Dr. Robinson comes to MUSC from the University of Michigan. Her research will help bridge a link between our growing dementia team and our premier stroke group by developing a better understanding of the links between stroke and cognitive decline. Dr. Robinson is a valued member of our team of researchers and clinicians who are
Towfique Raj Linkedin Twitter Google Research in our laboratory focuses on mechanisms underlying the regulation of gene expression and how these mechanisms are disrupted in neurodegenerative diseases. We use high-throughput functional genomics and genetic association studies to identify regions of the genome with functional effects on tissues and cells of the brain. We apply methods
Natura Myeku, PhD Linkedin Twitter Google Doctor Myeku’s lab has a long-standing interest in understanding the mechanism of deficient protein quality control in tauopathy disorders that have a common feature – accumulation of pathological tau. In particular, we are interested in studying the ubiquitin proteasome system (UPS), which is the principal pathway for protein turnover
Elizabeth Mormino, PhD Linkedin Google Dr. Beth Mormino completed a PhD in Neuroscience at UC Berkeley in the laboratory of Dr. William Jagust, where she performed some of the initial studies applying Amyloid PET with the tracer PIB to clinically normal older individuals. This initial work provided evidence that the pathophysiological processes of Alzheimer’s disease
Joe F. Abisambra Linkedin Twitter Google I obtained a BS in Biology (2002) at Saint Leo University in FL, and then relocated to Tampa, FL, where I earned a MS in Biochemistry and Molecular Biology (2004). I then joined Dr. Huntington Potter’s lab at the Byrd Alzheimer’s Institute, which was affiliated with USF, and defended
Katherine Bangen, PhD Linkedin Google Dr. Bangen completed her doctoral training at the San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology. Her research aims to better understand the functional and structural brain changes that occur in normal aging, mild cognitive impairment, and dementia. Her current projects utilize neuropsychological and
Timothy J. Hohman Linkedin Twitter Google Dr. Timothy Hohman is an Assistant Professor of Neurology and a cognitive neuroscientist. He received his doctoral degree in neuroscience from American University focusing on cognitive and neural changes during normal aging. He also completed a fellowship as part of the National Institutes of Health Graduate Partnership Program in
